ConductScience.org, home
K-562
API referenceFor AI assistants

Cell line · CVCL_0004

Papers341

1 more article gives this line's RRID in its Methods without naming the line nearby, so it is not listed.

1 to 20 of 341

Download this page as JSON
PaperJournalYearHow we knowRetractedSource
Circulating Tumour Cell GALNT13 Expression Is Associated with Prognosis and Treatment Response in Non-Small Cell Lung Cancer.Int J Mol Sci2026Its Methods give the RRID and name the linePubMed
Neutrophils suppress adaptive αβ T cells but not the innate γδ T cells and natural killer cells.Front Immunol2026Its Methods give the RRID and name the linePubMed
EBV hijacks the metabolic function of CD73 to resist the antitumor function of NK cells.NPJ Precis Oncol2026Its Methods give the RRID and name the linePubMed
Clustering of host N-glycans by the microneme MIC1/4/6 complex licenses Toxoplasma rhoptry discharge.EMBO J2026Its Methods give the RRID and name the linePubMed
A metabolic-oxidative axis contributes to NK cell cryo-vulnerability.iScience2026Its Methods give the RRID and name the linePubMed
PBMC-derive eNK cells was armed and promoted CAR-like response against tumors through armed with 16Fc21, a novel bispecific fusion protein for NK cells.Front Immunol2026Its Methods give the RRID and name the linePubMed
Identifying causal genetic variants for high-altitude adaptation through blood eQTL analysis in plateau populations.Commun Biol2026Its Methods give the RRID and name the linePubMed
Impact of IL-21 on CAR T-cell manufacturing: phenotypic, metabolic, and functional outcomes.Front Immunol2026Its Methods give the RRID and name the linePubMed
Development of humanized mouse models for the preclinical evaluation of NK cell-based therapies.Front Immunol2026Its Methods give the RRID and name the linePubMed
PARP Inhibitors plus Anlotinib as Bridging Therapy for Armored CAR-T Cells in Ovarian Cancer Enhances Infiltration and Antitumor Efficacy.Adv Sci (Weinh)2026Its Methods give the RRID and name the linePubMed
Meditope-Enabled Chimeric Antigen Receptors Facilitate Plug-and-Play Control of T Cells.Cancer Immunol Res2026Its Methods give the RRID and name the linePubMed
Systematic Targeting of Protein Complexes with Molecular COUPLrs.Cancer Discov2026Its Methods give the RRID and name the linePubMed
Periductal Fibroblast Density Defines Lymphocyte Exclusion via a CD44-Dependent Stromal Checkpoint in Pancreatic Cancer.Cancer Immunol Res2026Its Methods give the RRID and name the linePubMed
Preclinical Characterization of CLSP-1025, a First-in-Class, Mutation-Specific T-Cell Engager Targeting a Neoantigen Derived from a Common p53 Mutation.Clin Cancer Res2026Its Methods give the RRID and name the linePubMed
Identification of a Shiga toxin A-derived peptide internalized into Gb3 receptor-bearing cells via interaction with the Shiga toxin B subunit.FEBS Lett2026Its Methods give the RRID and name the linePubMed
Synergistic Induction of Caspase-8-Mediated Leukaemic Cell Death by Fisetin and Pinocembrin.Int J Mol Sci2026Its Methods give the RRID and name the linePubMed
A high-throughput modular microfluidic platform for versatile functional assays at single-cell level.Microsyst Nanoeng2026Its Methods give the RRID and name the linePubMed
Cytotoxic Profiling of 3',4',5'-Trimethoxychalcones Reveals Cell-Line-Dependent Cytotoxic Activity: An In Vitro and In Silico Study.Chem Biodivers2026Its Methods give the RRID and name the linePubMed
Optimizing Zirconium-89 labeling for chimeric antigen receptor T cell PET imaging by comparing desferrioxamine and oxine.Sci Rep2026Its Methods give the RRID and name the linePubMed
A fully human pan VL9 HLA-E TCRm antibody enables functional dissection of HLA-E biology and checkpoint signaling.iScience2026Its Methods give the RRID and name the linePubMed

cell-lines-2026-11-14-0.1.0

Next page

Sources 4

  • CellosaurusCC BY 4.0, with credit to Cellosaurus (SIB)
  • PubMed Central's articlesTitles shown only for CC0, CC BY and public domain articles
  • NLM's PMC Article DatasetsCourtesy of NLM, which does not endorse this database
  • PubMedNLM's terms
Each source's terms
  • CellosaurusCC BY 4.0. Cellosaurus's README: "we have chosen to apply the Creative Commons Attribution 4.0 International (CC BY 4.0) license to Cellosaurus (https://creativecommons.org/licenses/by/4.0/). This means that you are free to copy and redistribute Cellosaurus in any medium or format. You can remix, transform, and build upon Cellosaurus for any purpose, even commercially. You must give appropriate credit, provide a link to the license, and indicate if changes were made." Copyright (c) CALIPHO group, SIB Swiss Institute of Bioinformatics. Read on 14 Nov 2026 at https://ftp.expasy.org/databases/cellosaurus/README
  • PubMed Central's articlesEach article's own license. Its words show only under CC0, CC BY or public domain
  • NLM's PMC Article DatasetsNLM's PMC Article Datasets on AWS, https://registry.opendata.aws/ncbi-pmc. Its terms: users "acknowledge NLM as the source of the data in a clear and conspicuous manner", do not use the PubMed Central wordmark or the PMC logo, do not "indicate or imply that NLM/NIH/HHS has endorsed" a product, and "only distribute data that are licensed for redistribution". Each article keeps its own license: https://pmc.ncbi.nlm.nih.gov/about/copyright/
  • PubMedNLM's terms

Cellosaurus, SIB Swiss Institute of Bioinformatics, https://www.cellosaurus.org, CC BY 4.0. Its problem notes are given in its own words.

For software

Read this list from software.

Twenty rows a page, as JSON. No key.

GET https://conductscience.org/api/cell-lines/v1/CVCL_0004/papers

API referenceFor AI assistants